Abatacept Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project: An Extension Study

Trial Profile

Abatacept Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project: An Extension Study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Apr 2017

At a glance

  • Drugs Abatacept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 24 Feb 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2018 as reported by the ClinicalTrials.gov record.
    • 24 Feb 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2018 as reported by the ClinicalTrials.gov record..
    • 19 Oct 2014 Planned number of patients changed from 10 to 240 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top